IFNA1 and neoplasm: Increased mTNFα levels [18] along with enhanced cytotoxic activity of IFN-DCs from glioblastoma patients against autologous tumor cells after treatment with rIL-2 and dsDNA position these mediators as activators of the mTNFα-mediated cytotoxic effect.